A Decade of Research on Plant-Based Anticancer Compounds: A Scientometric Analysis
Mueen Ahmed KK Ahmed1★, Chaman Sab2★ Corresponding author
- 1Manuscript Technomedia, No. 9, St. Thomas Town, Bengaluru, Karnataka, INDIA.
- 2A.R.G. College of Arts and Commerce, Davanagere, Karnataka, INDIA.
CORRESPONDENCE
Mueen Ahmed KK Ahmed
Mueen Ahmed KKManuscript Technomedia, Bengaluru, Karnataka, INDIA..
Received: 07-04-2025; Revised: 12-06-2025; Accepted: 29-08-2025.
Volume 17, Issue 4 · pp. 1395–1397 · PUBLISHED Oct-Dec 2025 · DOI: 10.5530/pres.20250002
View on Pharmacogn. Res. original site ↗
ABSTRACT
Cancer continues to be one of the leading global health challenges, driving increasing scientific interest in natural and plant-derived therapeutic alternatives. This study presents a scientometric analysis of global research on plant-based anticancer compounds published between 1997 and 2025, with a particular focus on the past decade (2014–2023). A total of 279 publications were retrieved from the Web of Science database and analyzed using bibliometric techniques to map publication growth, research hotspots, collaborations, and citation impact. Findings indicate a consistent rise in scholarly output, with a sharp surge after 2017, reflecting the growing integration of phytochemistry, nanotechnology, and oncology. India, China, and the USA emerged as the leading contributors, supported by European and Middle Eastern collaborations. Prominent institutions include Comenius University (Slovakia) and NIPER (India), while key journals such as Journal of Ethnopharmacology and Phytomedicine have served as major publication venues. Keyword analysis revealed evolving themes from classical phytochemical mechanisms (apoptosis, angiogenesis inhibition) to emerging areas such as green nanotechnology, polyherbal synergism, and immunomodulation. Highly cited works emphasize the potential of synergistic phytochemical formulations and nanoparticle mediated delivery systems. Despite encouraging laboratory results, challenges such as assay variability, poor standardization of phytochemicals, and limited clinical translation remain major barriers. Future directions point toward integrating artificial intelligence, omics-based approaches, and sustainable green nanotechnology for advancing phytomedicine. This scientometric overview highlights the growing global emphasis on plant-based anticancer compounds, offering valuable insights for researchers, funding bodies, and policymakers to strengthen translational research in natural product oncology.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Ahmed, M. A. K., & Sab, C. (2025). A Decade of Research on Plant-Based Anticancer Compounds: A Scientometric Analysis. Pharmacognosy Research, 17(4), 1395–1397. https://doi.org/10.5530/pres.20250002
